Cargando…
The clinical effectiveness of REGEN-COV in SARS-CoV-2 infection with Omicron versus Delta variants
BACKGROUND: In vitro studies suggesting that REGEN-COV (casirivimab plus imdevimab monoclonal antibodies) had poor efficacy against Omicron-variant SARS-CoV-2 infection led to amendment of REGEN-COV’s Emergency Use Authorization to recommend use only in regions without high Omicron prevalence. REGEN...
Autores principales: | Gershengorn, Hayley B., Patel, Samira, Ferreira, Tanira, Das, Sankalp, Parekh, Dipen J., Shukla, Bhavarth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718412/ https://www.ncbi.nlm.nih.gov/pubmed/36459537 http://dx.doi.org/10.1371/journal.pone.0278770 |
Ejemplares similares
-
Real world SARS-COV-2 vaccine effectiveness in a Miami academic institution
por: Mallow, Christopher, et al.
Publicado: (2022) -
Linking prediction models to government ordinances to support hospital operations during the COVID-19 pandemic
por: Warde, Prem Rajendra, et al.
Publicado: (2021) -
Predictive Value of Sequential Organ Failure Assessment Score across Patients with and without COVID-19 Infection
por: Gershengorn, Hayley B., et al.
Publicado: (2022) -
Association of Race and Ethnicity with COVID-19 Test Positivity and Hospitalization Is Mediated by Socioeconomic Factors
por: Gershengorn, Hayley B., et al.
Publicado: (2021) -
Operational impact of decreased turnaround times for Candida auris screening tests in a tertiary academic medical center
por: Arenas, Sebastian, et al.
Publicado: (2023)